WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 462117
Description: 2’-O-Succinyl-cAMP is an immunogenic derivative of cAMP that has been used to generate anti-cAMP antisera and antibodies.
MedKoo Cat#: 462117
Chemical Formula: C14H16N5O9P
Exact Mass: 429.0686
Molecular Weight: 429.2818
Elemental Analysis: C, 39.17; H, 3.76; N, 16.31; O, 33.54; P, 7.22
Synonym: 2’-O-Succinyl-cAMP; 2’-O-Succinyl-3’,5’-cyclic AMP
IUPAC/Chemical Name: 4-(((4aR,6R,7R,7aR)-6-(6-amino-9H-purin-9-yl)-2-hydroxy-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl)oxy)-4-oxobutanoic acid
InChi Key: QNPSLGPIZRJDAN-UISLRAPISA-N
InChi Code: InChI=1S/C14H16N5O9P/c15-12-9-13(17-4-16-12)19(5-18-9)14-11(27-8(22)2-1-7(20)21)10-6(26-14)3-25-29(23,24)28-10/h4-6,10-11,14H,1-3H2,(H,20,21)(H,23,24)(H2,15,16,17)/t6-,10-,11-,14-/m1/s1
SMILES Code: NC1=C2C(N([C@]3([H])O[C@@](COP(O4)(O)=O)([H])[C@]4([H])[C@H]3OC(CCC(O)=O)=O)C=N2)=NC=N1
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 429.2818 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1: Ezan, E., Mamas, S., Rougeot, C., et al. Strategies for developing specific and sensitive hapten radioimmunoassays. Radioimmunoassay in Basic and Clinical Pharmacology 143-179 (1987).
2: Denizot, F.C., Hirn, M.H., and Delaage, M.A. Relationship between affinity and kinetics in a hapten--antibody reaction. Studies on anti-cyclic AMP antibodies. Mol. Immunol. 16(7), 509-513 (1979).